Friday Night Inc. Moving Higher After Providing Update on Latest Acquisition
Numerous companies have disclosed acquisitions today. This, to no surprise, has sent the stock prices of these companies soaring. However, there is one company, in particular, that is making serious waves in the market after ... [Read]
Sorrento Therapeutics Trading Lower Today, But Why?
It looks like not every biotechnology company is doing well in the stock market today. I guess that’s how the game works, though. If there’s a winner, there also has to be a loser. It’s ... [Read]
Why is Innovus Pharmaceuticals Trading Up Nearly 30% Today?
As we move closer to the end of the month, with only two and half weeks left, it’s safe to say that the month of January has proven to be very beneficial for Innovus Pharmaceuticals ... [Read]
Aradigm Corporation Dropped More Than 30% Today, Here’s Why
Regardless of whether or not you are an Aradigm Corporation (NASDAQ:ARDM) shareholder, it is crucial that the entire marketplace becomes aware of the latest news surrounding the Hayward, California-based specialty pharmaceutical company. What’s Happened? Despite ... [Read]
Agile Therapeutics Denied Approval By FDA for Contraceptive Patch, But the Problem May Be With the FDA, Not the Patch
Agile Therapeutics, Inc. (NASDAQ:AGRX) took a nasty blow today when it announced that the FDA would not be approving Agile’s contraceptive patch Twirla. This is, in fact, the second time that Twirla has been denied ... [Read]
Hydropothecary Acquires Additional 78 Acres, On Track for Expansions
The Hydropothecary Corp. (TSXV:THCX) is making progress on its plans for expansion. The company has just recently acquired 78 acres, in addition to its already-owned 65-acre facility. With this additional land, Hydropothecary is on track ... [Read]
Impax Laboratories Receives Tentative Approval for Generic Coreg CR Extended-Release Capsules
Impax Laboratories, Inc. (NASDAQ:IPXL) has received tentative US FDA approval on its Abbreviated New Drug Application. The application was for a generic form of Coreg CR (carvedilol phosphate) extended-release capsules, in quantities of 10, 20, ... [Read]
Impax Laboratories Being Investigated For Merger with Amneal Pharmaceuticals
The Impax Laboratories (NASDAQ:IPXL) Board of Directors is being investigated by the stock legal firm Brower Piven in regards to its impending merger with Amneal Pharmaceuticals. Brower Piven is looking into prospective breaches of fiduciary ... [Read]
Hydropothecary Creates Stock Option Grants for Directors and Officers
The Hydropothecary Corp. (TSXV:THCX) has made stock option grants available to its directors and officers. Under its stock option plan, the grant is to acquire a total of 1.75 million common shares of the company. There ... [Read]
Hydropothecary Awarded with Best New Cannabis Product for Decarb and Elixir Strains
The Hydropothecary Corp. (TSXV:THCX) was awarded the Best New Cannabis Product at the inaugural annual Canadian Cannabis Awards gala. Two of Hydropothecary’s products received this recognition. Decarb, the company’s ready-to-consume activated and edible cannabis powder, ... [Read]